17-Jul-2012 - Carl Zeiss AG

Carl Zeiss Licences Digital Pathology from Olympus

Carl Zeiss Microscopy GmbH and Olympus America Inc. have signed a nonexclusive worldwide licensing agreement allowing Carl Zeiss to access an extensive portfolio of patents held by Olympus in the field of digital pathology and virtual microscopy. The patents included in the licensing deal cover methods and equipment for creating, storing and delivering virtual microscopy slides. The technology enables individuals to view and share high-resolution virtual microscopy images over the Internet.

"The handling of digital data has become a major driver of the development of modern microscopy,” said Dr. Bernhard Ohnesorge, Member of the Board and General Manager BioSciences Division of Carl Zeiss Microscopy. “Integrating the virtual slide functionality into our research microscope systems will enable our customers to become more efficient and to explore new scientific approaches. This will help them to better understand the root causes of the most challenging diseases.”

“Global adoption of digital slide scanning continues to expand into new medical and scientific applications,” said Brad Burklow, Executive Director Business Development, Scientific Equipment Group, Olympus Corporation of the Americas. “Olympus is the holder of many important patents in this area, and we feel it is vital to allow broad access to these technologies in order to advance the field of pathology and medical research. We are confident that leveraging these technologies will enhance healthcare for patients around the world.”

The companies are not making specific terms and conditions of the agreement public.

Facts, background information, dossiers
  • Carl Zeiss
  • Olympus
  • pathology
More about Carl Zeiss
  • News

    ZEISS Reports Successful Start to Fiscal Year

    The ZEISS Group had a successful end to the first six months of fiscal year 2020/21 (ended 31 March 2021). It saw its revenue rise by 6 percent (adjusted for currency fluctuations, by 9 percent) to 3.406 billion euros (previous year: 3.213 billion euros). Around 90% of this sum was generate ... more

    BOSELLO now fully part of the ZEISS Group

    ZEISS and BOSELLO HIGH TECHNOLOGY (BOSELLO) announce that the Italian supplier of solutions for industrial X-ray systems, is now fully part of the ZEISS Group and will operate under the name Carl Zeiss X-ray Technologies Srl. In 2018, ZEISS acquired a majority stake in BOSELLO to strengthen ... more

    ZEISS Invests by Acquiring Majority Stake in arivis AG

    ZEISS is expanding its imaging technology capabilities with 3D and big image data software by acquiring a majority stake in the imaging business of arivis. With this investment, ZEISS is further strengthening its software competencies and market position in 3D image visualization, image pro ... more

  • Videos

    Carl Zeiss Microscopy GmbH

    more

More about Olympus